Primary record
1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide; 1-[(2,6-Difiuorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide; Banzel; CGP 33101; E 2080; Inovelon; RUF 331; Rufinamide
- 库存
- 3,310 克
- 纯度
- 99.6 %
- CAS
- 106308-44-5
化合物标识与属性
- CAS
- 106308-44-5
- PubChem CID
- 129228
- SMILES
- C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F
- Canonical SMILES
- NC(=O)c1cn(Cc2c(F)cccc2F)nn1
名称与同义词
- Rufinamide
- Inovelon
- Banzel
- 106308-44-5
- Xilep
- Rufinamida
- Cgp 33101
- rufinamidum
- Inovelon/Banzel
- Rufinamide?
- CGP-33101
- 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
- Banzel, Rufinamide
- RUF 331
- RUF-331
- Banzel (TN)
- Rufinamide (Banzel)
- Rufinamide-15N-d2
- Rufinamide (Standard)
- C10H8F2N4O
- RefChem:57756
- RUFINAMIDE [MI]
- RUFINAMIDE [INN]
- RUFINAMIDE [JAN]
- Rufinamide (USAN/INN)
- RUFINAMIDE [USAN]
- UNII-WFW942PR79
- WFW942PR79
- DTXSID1046506
- RUFINAMIDE [VANDF]
- D02OBK
- D0MD2L
- Rufinamide [USAN:INN:BAN]
- AC1L2V8C
- RUFINAMIDE [MART.]
- POGQSBRIGCQNEG-UHFFFAOYSA-N
- SYN111
- RUFINAMIDE [USP-RS]
- RUFINAMIDE [WHO-DD]
- SYN11
- DTXCID9026506
- Rufinamide (JAN/USP/INN)
- MLS001332513
- MLS001332514
- RUFINAMIDE [EMA EPAR]
- SCHEMBL230448
- RTI-177
- SYN-111
- 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide
- MFCD00865314
- 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide
- GTPL7470
- orb1305361
- ZINC7782
- CGP33101
- CHEMBL1201754
- E-2080
- E2080
- RUFINAMIDE [ORANGE BOOK]
- CTK8E9248
- HY-A0042R
- KS-00000YSQ
- N03AF03
- CHEBI:134966
- s1256
- GLXC-07965
- HMS2232M19
- HMS3262O14
- HMS3371A06
- HMS3651O05
- HMS3884G07
- HMS5079F03
- RUFINAMIDE [USP MONOGRAPH]
- CGP 33,101
- BCP21828
- HY-A0042
- MSK15642
- VGA93995
- VWC03748
- C10-H8-F2-N4-O
- Tox21 112267
- Tox21_112267
- Tox21_500796
- AN-598
- BDBM50515492
- CID129228
- E 2080
- EBC-12722
- HB1039
- NCGC00165883-02
- RTI 4229-177
- AKOS005145897
- Rufinamide, >=98% (HPLC), powder
- Tox21_112267_1
- AC-1429
- AS07135
- CCG-222100
- CID:129228
- CS-1455
- CS-O-02240
- DB06201
- FD61593
- LP00796
- SB18904
- SDCCGSBI-0633757.P001
- NCGC00165883-01
- NCGC00165883-03
- NCGC00165883-04
- NCGC00165883-11
- NCGC00261481-01
- AS-13861
- BC224496
- Q503
- SMR000857122
- ZB000661
- SID:135653558
- AB0017630
- AB1008455
- J575.180B
- RT-015464
- AK00592772
- B2280
- CAS-106308-44-5
- FT-0656828
- FT-0674479
- NS00000547
- R0143
- SW219770-1
- C71253
- D05775
- EN300-120881
- J10459
- W-5135
- 1H-1,2,3-Triazole-4-carboxamide, 1-((2,6-difluorophenyl)methyl)-
- 1H-1,2,3-Triazole-4-carboxamide, 1-[(2,6-difluorophenyl)methyl]-
- AB00918347-05
- AB00918347_06
- 308R445
- A801414
- C079703
- F799818
- Q408565
- SR-01000842156
- 170939-95-4
- I06-1425
- SR-01000842156-4
- 1-((2,6-difluorophenyl)methyl)triazole-4-carboxamide
- BRD-K20079257-001-09-6
- 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide
- F0001-2404
- Z1532717444
- 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazol-4-carboxamide
- Rufinamide, 98%, a sodium channel blocker - 100MG 100mg
- Rufinamide, United States Pharmacopeia (USP) Reference Standard
- 1-[Dideuterio-(2,6-difluorophenyl)methyl]triazole-4-carboxamide
- 1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfanyl)phenoxy]phenyl]urea
- RUF 331; CGP 33101; 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
- 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide; 1-[(2,6-Difiuorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide; Banzel; CGP 33101; E 2080; Inovelon; RUF 331; Rufinamide
- 106310-22-9
- 1795037-48-7
- CGP-33101; CGP 33101; CGP33101; E 2080; RUF 331;; E2080; RUF331;; E-2080; RUF-331